Clinical trial
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
NCT00701935 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
- Lead sponsor
- AstraZeneca
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- August 31, 2008
- Completion date
- January 31, 2012
- Enrollment
- 80 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.